We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Individualized Neurodevelopmental Treatment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00922077
First Posted: June 17, 2009
Last Update Posted: June 17, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hellenic Society for Disabled Children
  Purpose
The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.

Condition Intervention Phase
Cerebral Palsy Behavioral: standard physical therapy program with emphasis on dynamic balance exercises Phase 3

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: Individualized Neurodevelopmental Treatment

Resource links provided by NLM:


Further study details as provided by Hellenic Society for Disabled Children:

Enrollment: 1
Study Start Date: January 2008
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Detailed Description:
The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years to 9 Years   (Child)
Sexes Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • spastic tetraplegia

Exclusion Criteria:

  • vision problems
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00922077


Locations
Greece
Hellenic Society for Disabled Children
Thessaloniki, Greece, 25155
Sponsors and Collaborators
Hellenic Society for Disabled Children
  More Information

Responsible Party: Gait Laboratory ELEPAP THESSALONIKI
ClinicalTrials.gov Identifier: NCT00922077     History of Changes
Other Study ID Numbers: 001-Nikodelis
First Submitted: June 1, 2009
First Posted: June 17, 2009
Last Update Posted: June 17, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases